[Complications of intracavernous pharmacologic infusion in impotence. Long-term results]. / Le complicanze del trattamento FIC nell'impotenza. Risultati a distanza.
Minerva Urol Nefrol
; 45(3): 109-12, 1993 Sep.
Article
em It
| MEDLINE
| ID: mdl-8278876
ABSTRACT
The large scale employment in recent years of vasoactive drugs in the treatment of impotence forms the basis for a significant statistical study on incidence of complications and collateral effects. We studied 658 patients submitted to ICF (intracavernous pharmacoinfusion) diagnostic and therapeutic in the last 6 years (1986-1992). The patients have been shared groups according to the period and the treatment in 226 cases we have utilized papaverine, in 224 cases phentolamine-papaverine association and in 208 cases prostaglandin E1. In the last group the complications have been lower echymosis and haematoma 0.5%, priapism 1.5%, intracavernous fibrosis 1%, fibrotic knots 0.5%. In conclusion we confirm the validity of treatment with PGE1 intracavernous infusion.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Papaverina
/
Doenças do Pênis
/
Fentolamina
/
Alprostadil
/
Disfunção Erétil
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
It
Revista:
Minerva Urol Nefrol
Assunto da revista:
NEFROLOGIA
/
UROLOGIA
Ano de publicação:
1993
Tipo de documento:
Article